HOOKIPA PHARMA INC

De la TradeVille.ro wiki
Versiunea din 1 octombrie 2024 09:24, autor: 127.0.0.1 (discuție) (The LinkTitles extension automatically added links to existing pages (https://github.com/bovender/LinkTitles).)
(dif) ← Versiunea anterioară | Versiunea curentă (dif) | Versiunea următoare → (dif)

Pagina dedicata companiei HOOKIPA PHARMA INC listata cu simbolul US.HOOK

Descriere companie[edit | ]

HOOKIPA Pharma Inc.(https://www.hookipapharma.com/) is a clinical-stage biopharmaceutical company. The Company develops immunotherapeutics based on its arenavirus platform that are designed to target and amplify a T cell and immune response to disease. The Company's infectious and oncology product candidates HB-101, HB-201, HB-202 and HB-300. The infectious disease product candidate, HB-101, is in a randomized, double-blinded Phase II clinical trial in cytomegalovirus-negative patients awaiting kidney transplantation from cytomegalovirus-positive donors. Its lead oncology product candidates, HB-201 and HB-202, are in development for the treatment of human papillomavirus-positive cancers. The Company is developing its self-antigen project in this area, HB-300, as a replicating technology-based product candidate in metastatic, hormone-resistant prostate cancer.

Grafic actiuni companie[edit | ]

Ultimele stiri despre HOOKIPA PHARMA INC (US.HOOK)[edit | ]

Adus de la „https://wiki.tradeville.ro/index.php?title=HOOKIPA_PHARMA_INC&oldid=448089”